tovx: the income statement

MyFinsight

Theriva Biologics, Inc. (TOVX)

For the quarter ending 2025-06-30, TOVX made $74K in revenue. -$13,058K in net income. Net profit margin of -17645.95%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Research and development	1,953
General and administrative	11,179
Total operating costs and expenses	13,132
Loss from operations	-13,132
Interest income, net	54
Foreign currency exchange (loss) gain	20
Total other income	74
Net loss	-13,058
Net loss attributable to common stockholders	-13,058

Earnings per share, basic	-1.93
Earnings per share, diluted	-1.93
Weighted average number of shares outstanding, basic	6,752,953
Weighted average number of shares outstanding, diluted	6,752,953

Unit: Thousand (K) dollars (except for numbers of shares and EPS)